BioVaxys Technology Corp. (BVAXF)

[TomBradysEgo]

Going balls deep on this Monday. Damn this is good.

[Dr_Vonschellan]

Informative_snapshot cross_comparison chart_on vaccines
https://www.bbc.com/news/health-51665497

The ideal vaccine should be:
1. One dose.
2. Stores in a regular kitchen type refrigerator.
3. Better than 86% efficacy (preferably closer to mid-90%).
4. Able to suppress/kill the new Covid-19 variations.

That's a tall order, but this is the new bar government officials want us to shoot for obviously. I'm sure our guys are aiming to help in this area.

The Doctor

[Pennyes]

BioVaxys and FDA permits, in extraordinary circumstances FDA can approve even the unapproved or products that are not evaluated, because of dire need!...
BioVaxys seems to be spearheading for T cell diagnostic tests using their patented test tools!... unique or not, it is a necessity right now...and huge potential!!!

Covid-T™ Clinical Development Program Initiated Regulatory Advisory Group Engaged

VANCOUVER, BC, Jan. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to announce that it has initiated the clinical development program for Covid-T™, the Company's novel diagnostic platform for detecting T-cell activity. The US Food and Drug Administration ("FDA") has tentatively agreed to permit that BioVaxys can file for a pre-Emergency Use Authorization ("EUA") for Covid-T™. Under an EUA, FDA may allow the use of unapproved medical products, or unapproved uses of approved medical products in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions when certain statutory criteria have been met, including that there are no adequate, approved, and available alternatives.

https://www.otcmarkets.com/stock/LMNGF/news/story?e&id=1795890

[Termite7]

Great updates, thanks!!!

[Major_Bankz]

LMNGF maybe HUGE!, Here is the Moderna Video not effective against the African variant ==> https://finance.yahoo.com/news/coronavirus-is-going-to-stay-with-us-forever-moderna-ceo-224622557.html

[Major_Bankz]

LMNGF BOOOOOOOOM $0.34

[Major_Bankz]

BOOOOOOOOM $0.20

[Major_Bankz]

BOOOM HUGE NEWS! ==> BioVaxys Announces Initiation of Cancer Vaccine EU Clinical Program, Completion of BVX-0320 Preclinical Program
Mon, January 25, 2021, 8:04 AM


VANCOUVER, BC, Jan. 25, 2021 /CNW/ --

Features Observation Of Neutralizing Antibodies To SARS-CoV-2

Advancement Of Viral Vaccine Platform And T-cell Diagnostic To Address Emerging SARS-CoV-2 Strains

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to provide a corporate update on recent advancements of its vaccine platforms, and viral diagnostic and corporate objectives for 2021. BioVaxys is pleased to announce that it has commenced the clinical development program for BVX-0918A, its haptenized tumor antigen vaccine for ovarian cancer. The Company plans to seek a compassionate use approval in the European Union ("EU") for Stage III & Stage IV ovarian cancer, followed by submitting an IND in the US. BioVaxys is in discussions with its designated Contract Manufacturing Organization ("CMO") and anticipates the execution of a manufacturing contract in 1Q21. The Company plans to submit its Clinical Trial Application ("CTA") for BVX-0918A with the European Medicines Agency ("EMEA") later this year.

There are significant unmet therapeutic needs for ovarian cancer treatment. Over 240,000 women are currently diagnosed with ovarian cancer worldwide, and over 140,200 succumbed to the disease. Ovarian cancer is the leading cause of death from gynecologic malignancy in the United States. An estimated 21,750 new cases of ovarian cancer are expected in the United States in 2020 with 13,940 deaths. The case-to-fatality ratio is nearly three times that of breast cancer and makes ovarian cancer the deadliest gynecologic malignancy in developed countries. Like other cancers, the stage of disease is inversely proportional to survival. The 5-year relative survival rate in all stages of the disease is approximately 45%. However, ovarian cancer is usually asymptomatic in the early stages (Stage I and Stage II), and therefore about 80% of patients are diagnosed with advanced stage disease (stages III and IV). The 5-year survival rate for stage III and IV patients is approximately 29%.[1]

[Major_Bankz]

BioVaxys Announces Initiation of Cancer Vaccine EU Clinical Program, Completion of BVX-0320 Preclinical Program
Mon, January 25, 2021, 8:04 AM


VANCOUVER, BC, Jan. 25, 2021 /CNW/ --

Features Observation Of Neutralizing Antibodies To SARS-CoV-2

Advancement Of Viral Vaccine Platform And T-cell Diagnostic To Address Emerging SARS-CoV-2 Strains

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to provide a corporate update on recent advancements of its vaccine platforms, and viral diagnostic and corporate objectives for 2021. BioVaxys is pleased to announce that it has commenced the clinical development program for BVX-0918A, its haptenized tumor antigen vaccine for ovarian cancer. The Company plans to seek a compassionate use approval in the European Union ("EU") for Stage III & Stage IV ovarian cancer, followed by submitting an IND in the US. BioVaxys is in discussions with its designated Contract Manufacturing Organization ("CMO") and anticipates the execution of a manufacturing contract in 1Q21. The Company plans to submit its Clinical Trial Application ("CTA") for BVX-0918A with the European Medicines Agency ("EMEA") later this year.

There are significant unmet therapeutic needs for ovarian cancer treatment. Over 240,000 women are currently diagnosed with ovarian cancer worldwide, and over 140,200 succumbed to the disease. Ovarian cancer is the leading cause of death from gynecologic malignancy in the United States. An estimated 21,750 new cases of ovarian cancer are expected in the United States in 2020 with 13,940 deaths. The case-to-fatality ratio is nearly three times that of breast cancer and makes ovarian cancer the deadliest gynecologic malignancy in developed countries. Like other cancers, the stage of disease is inversely proportional to survival. The 5-year relative survival rate in all stages of the disease is approximately 45%. However, ovarian cancer is usually asymptomatic in the early stages (Stage I and Stage II), and therefore about 80% of patients are diagnosed with advanced stage disease (stages III and IV). The 5-year survival rate for stage III and IV patients is approximately 29%.[1]

[Major_Bankz]

LMNGF 0.1852 NEWS OUT!

[Dr_Vonschellan]

Termite7,_none. The_is just_another Jeremy_scam gone_sour. Run_away

[Termite7]

Hey, what's the upside? Thanks!!

[Dr_Vonschellan]

Ohhh_Jeremy, You've_put us_on the_Bearing Express_Train to_nowhere again
We should have known where we were going when this train rolled out of the station. We wanted to believe things had changed with you... but it is the same old Jeremy train into the toilet we rode down in Bearing.

Ah well, at least this pig will offset gains in other stocks someday helping minimize our tax bills.

The Doctor

[Dr_Vonschellan]

Dear_Jeremy, Are we on_this rising_Tsunami?
https://www.scmp.com/news/china/science/article/3110314/coronavirus-vaccine-developed-china-induces-quick-immune

The Doctor

[Dr_Vonschellan]

Dear_Jeremy @LMNGF/Biovaxys, Did_we/you just_buy all_the Llamas on_our project?
That is, buy all the Llamas on our old project in Maricunga Chile?
https://nypost.com/2020/11/06/llama-nanobodies-are-powerful-new-covid-19-treatment-study/

The Doctor

[TIMBERWOLF]

Omron Trades under OMRNY Currently 74.73 per share

https://www.otcmarkets.com/stock/OMRNY/profile

David Wang, a seasoned medical technology executive, is Healthcare Consultant for South America for Omron, an USD$1.5 billion market capitalization company listed on the Tokyo Stock Exchange. Mr. Wang is the former CEO of CAUS Capital and the former CEO of Beijing Century Medical and is fluent in Chinese and Japanese.

[TIMBERWOLF]

News.. New Officers

https://www.otcmarkets.com/stock/LMNGF/news/story?e&id=1719929

[Dr_Vonschellan]

Well_Dear LIEG alumni... we're_smack dab_in it now
https://biovaxys.com/
We've certainly have come a long WAY since Maricunga Chile via Jeremy's Lions Bay Mining (LMNGF) to the bright lights of Broadway, not that far from our new office 1177 Avenue of the Americas, 5th Floor, New York NY 10036. We're scientists wearing white coats now, no more dirty mining coveralls mucking around in the dirt/salt for us beaners.

Looks like we're fighting the dangerous Covid19-like virus family and cancer now... which in theory should be a whole lot easier than fighting the Deep State Fascists, Codelco, Pinera, the old Nelson Pizarro crew, and Prokurica back in our homeland Chile.

Dear Uncle Posco, did you pack a warm overcoat and your long johns? You're gonna' need them this winter.

The Doctor

[Dr_Vonschellan]

The huge return on investing in coronavirus tests
https://www.axios.com/coronavirus-testing-investment-eca1e901-8cbe-4015-b77a-594e4dc6c16d.html

The Doctor

[Renee]

Lions Bay Mining Corp. changed to BioVaxys Technology Corp.

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

[Dr_Vonschellan]

Why_did we_jump to $.20pps today? Because_US lawmakers_and their_donors
have finally reached the point that they have secretly through untraceable Panama & Cayman Island corporations bought enough shares in local miners that they can now make some whopping big profits on lithium mining in Nevada.

Story
https://cleantechnica.com/2020/05/13/nevadas-lithium-valley/

Video

The Doctor

[Dr_Vonschellan]

Are we (LMNGF) actually going to be born?
https://insideevs.com/news/419466/tesla-nevada-lithium-supply-potential/

I think Trump just realized his days of getting cheap Lithium from China are nearly over... he has stabbed one too many Chinese in the back over this corona-virus fiasco and now the coming retribution (from China) is going to really sting America.

China: We discovered a new virus.
America: So what?

China: It's Dangerous
America: It's only a Flu

China: Wear a Mask
America: Don't wear a Mask
... pic.twitter.com/Qxugv8z73J

— China Xinhua News (@XHNews) April 30, 2020

Nevada's Lithium Valley could finally be waking from hibernation and coming alive... let's begin by watching Tesla first off a little bit closer now.

And of course we will be watching our neighbors also... much closer... https://www.mining.com/web/lithium-developer-ioneer-forecasts-high-margins-for-nevada-project/

The Doctor

[Dr_Vonschellan]

US quandary: securing weapons-grade minerals without China
https://www.mining.com/web/american-quandary-how-to-secure-weapons-grade-minerals-without-china/

Is our project(s) about to get a huge financial stimulus Kick in the ass to open from the DOD and start producing "rare" minerals stateside for the Pentagon?

The Doctor

[Dr_Vonschellan]

Surprise surprise, absolutely zero happening here on LMNGF
... a good day for us is over 100 shares trading on this POS that Jeremy invented.

The Doctor

[Dr_Vonschellan]

Welcome_Pilgrim, please_watch_the video first_then join_the discussion_on_Bearing
as we all try to figure WTF is really going on here.

Video

Bearing Lithium Corp BLILF iHub Board https://investorshub.advfn.com/Bearing-Lithium-Corporation-OTC-BLILF-36086/

The Doctor